Bronchopulmonary Dysplasia of Newborn

DBCOND0130247Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesPregnancy, Puerperium, and Perinatal Conditions

Bronchopulmonary Dysplasia of Newborn is the indication for 2 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Bronchopulmonary Dysplasia · Bronchopulmonary Dysplasia (BPD) · Chronic Lung Disease of Prematurity · BPD - Bronchopulmonary Dysplasia · Broncho Pulmonary Dysplasia
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0002980ICD-10P27.1SNOMED CT67569000MedDRA10006475UMLSC0006287

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
145Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Bronchopulmonary Dysplasia of Newborn share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In